SCHEMBL845171

SCHEMBL845171

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3)cc2)cc1)C1CC1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
ITGB1 P05556 5/20 0.51
ITGA4 P13612 5/20 0.51
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HCRTR1 O43613 2/20 0.47
HCRTR2 O43614 2/20 0.47
KDM1A O60341 1/20 0.47
RCOR1 Q9UKL0 1/20 0.47
PABPC1 P11940 1/20 0.46
FKBP1A P62942 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845205 0.96 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL845111 0.96 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL13272444 0.96 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL1030175 0.96 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL845226 0.96 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL15116912 0.96 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL845160 0.92 HSD11B1 (0.53) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL845154 0.91 ALDH1A1 (0.54) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL845406 0.91 ALDH1A1 (0.54) ALDH1A1ITGB1ITGA4KDM4ELMNA
SCHEMBL845408 0.91 ALDH1A1 (0.54) ALDH1A1ITGB1ITGA4KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed